Applicant, as named in the Orange Book

Dr Reddys

Dr. Reddy's Laboratories Ltd · NYSE: RDY

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Cyclophosphamide on 15 Feb 2036. 1 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Cyclophosphamide NDA 212501 · 3 strengths cyclophosphamide	cyclophosphamide	15 Feb 2036 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Ssd NDA 018578 silver sulfadiazine	silver sulfadiazine	open now no listed protection	no listed protection